NCT07599241 Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues
| NCT ID | NCT07599241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Subclinical hypothyroïdism |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-03-15 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
Eligibility Criteria
Inclusion Criteria: * subclinical hypothrodism (significant form) * primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma) * fatty liver (non alcholic type) * elder females Exclusion Criteria: * respiratory issues * cardiac issues * renal issues
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07599241 clinical trial?
This trial is open to female participants only, aged 65 Years or older, up to 75 Years, studying Subclinical hypothyroïdism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07599241 currently recruiting?
Yes, NCT07599241 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07599241 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07599241 clinical trial?
NCT07599241 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.